Fibroblast proliferation regularly impedes the initiation and maintenance of pancreatic islet monolayers in culture. We recently characterized a specific cytotoxin to cells expressing the basic fibroblast growth factor receptor by conjugating the growth factor to saporin-6, a ribosome-inactivating protein. In contrast to untreated islets, isolated adult rat islets grown on a substrate prepared from bovine corneal endothelial cells and incubated with the mitotoxin at 10-nM concentration for 96 h were free of contaminating fibroblasts. Histological and functional studies revealed there was no damage to the islets. The results suggest that treatment of this cell type with basic fibroblast growth factor mitotoxins may be an important tool for culture of pure islets for physiological and clinical studies. Diabetes 39:1002-1005,1990 F ibroblast contamination has been a serious obstacle to the induction and maintenance of pancreatic islet monolayers. Their rapid proliferation inhibits the survival of the endocrine cells, seriously limiting the possibility of long-term culture (1). To rid the cell cultures of fibroblasts, several approaches have been used: decantation of pancreatic cell suspensions into new dishes after a few hours of culture, followed by culture in medium free of cysteine and serum (2), or adding to the medium inhibitors of fibroblast growth, including thimerosal (3), iodoacetic acid (4), and 2-deoxyglucose (1). These measures, however, have met with limited success. We investigated the feasibility of using a mitotoxin that was initially designed to specifically eliminate cells that express the basic fibroblast growth factor (FGF) receptor (5). The mitotoxin, a chemical conjugate between basic FGF and the ribosome-inactivating protein saporin, which binds to the high-affinity basic FGF receptor, is internalized and inhibits protein synthesis leading to cell death. We exploited the presence of the basic FGF receptor on contaminating fibroblasts to selectively remove these cells from cultures of rat islet monolayers.
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RESEARCH DESIGN AND METHODS
Recombinant basic FGF was kindly provided by Dr. Paolo Sarmientos (Farmitalia, Milan, Italy). Saporin-6 was purified from the seeds of the plant Saponaria officinalis according to previously published methods (6) . The conjugation of the basic FGF with saporin and the purification of the conjugate has been described elsewhere (5) . The cytotoxic activity of the conjugate was tested on a 3T3 mouse fibroblast cell line in concentrations ranging from 0.001 to 10 nM. In this assay, 3T3 cells were diluted in HEPES-buffered Dulbecco's modified Eagle's medium with 10% fetal bovine serum to a concentration of 20,000 cells/ml and plated in 24-well plates. The plates were incubated overnight at 37°C with 5% CO 2 . The next morning, the medium was aspirated from the wells and replaced with medium alone for controls or with medium containing the conjugate or saporin alone. The cells were washed twice in serum-free medium 72 h later, trypsinized, and diluted, and cell number was determined with a Coulter particle counter.
The islets used in these experiments were isolated from highly inbred Lewis rats originally obtained through the National Institutes of Health Grantee Reimbursement Program from the Charles River Breeding Laboratories (Charles River, MA). Male rats, 150-250 g, were used as donors. Islets were isolated by the method of Lacy and Kostianovsky (7) with collagenase B (Boehringer-Mannheim, Indianapolis, IN) for digestion, reversibly stained with dithizone (Sigma, St. Louis, MO; 8) and handpicked under direct vision with a stereomicroscope.
A bovine corneal endothelial cell matrix (BCEM) was prepared by lysing confluent bovine corneal endothelial cells with 1 mM ammonium hydroxide for 15 min (9). Islet mono-layer formation was initiated on BCEM-coated 24-well plates with 20 islets/well in RPMI-1640 medium containing 22.2 mM glucose and 10% fetal calf serum as previously described (10) . At this time, the substances to be tested for the inhibition of fibroblast growth were added. The medium was changed after 48 h, and fresh factors were added. Islet attachment and the extent of endocrine and fibroblast proliferation were determined by visual examination with a phase-contrast microscope at 96 h. At that time, fresh medium without the test additives was added.
At the end of 5 days, monolayers were stimulated with glucose to measure insulin release into medium in response to glucose stimulation. The cells were washed twice in KrebsRinger bicarbonate buffer, pH 7.4, supplemented with 2 mg/ ml of bovine serum albumin, and incubated for 1 h with low (1.6 mM) or high (16.7 mM) glucose content. Insulin release into buffer was measured by radioimmunoassay (10) .
Monolayers were fixed overnight at room temperature in 1% formalin in phosphate-buffered saline. Cells were permeabilized by incubation with 1% Nonidet P-40 in phosphate-buffered saline for 15 min and stained with the immunoalkaline phosphatase technique (11) with pork anti-beef insulin (Chemicon, El Segundo, CA) as the primary antibody. The slides were counterstained with hematoxylin.
Student's t tests for paired data were performed by use of the Crunch statistical package (Jandel, San Francisco, CA). Figure 1 shows that, at a concentration of 10 nM, saporin alone has only a slight inhibitory effect on proliferation of 3T3 cells. In contrast, the basic FGF-saporin conjugate is a potent cytotoxin. Therefore, 10 nM was the concentration used in our studies with islet monolayers.
RESULTS
The addition of 10 nM basic FGF-saporin had no deleterious effect on the adherence of the islets to the BCEM or to the production of endocrine monolayers (Table 1) . However, there was virtually complete inhibition of the growth of fibroblasts around the endocrine monolayer in the mitotoxintreated dishes. There was no inhibitory effect of equimolar concentration of basic FGF, saporin, or a mixture of the two, demonstrating the specificity of the mitotoxin activity. At higher concentrations of saporin (1 |xM), there was a nonspecific cytotoxic effect in which endocrine and fibroblast cells were inhibited, both from adhering to the matrix and from forming monolayers.
The effect of the mitotoxin on fibroblast growth is apparent in Fig. 2 . In the untreated dishes, endocrine monolayers are surrounded by fibroblasts, whereas in the treated dishes, the area around the endocrine monolayer is free from nonepithelial cells. Most of the endocrine cells in the monolayer stained for insulin (not shown). Insulin release in control and mitotoxin-treated cells was comparable after stimulation of the cells by glucose (Fig. 3) . The difference in response between basal and stimulated release was highly significant in both groups (P < 0.001).
DISCUSSION
The detrimental effects of fibroblast contamination of cultured pancreatic islets are well described (1-4). We previously showed that it is possible to eliminate contaminating fibroblasts in monolayer cultures of neonatal islets by keeping the islets free floating in petri dishes for 5 days before the transfer of the islets to BCEM-coated dishes (10) . However, this approach is not always feasible. As an example, the survival of adult islets is curtailed under these conditions, and fibroblast contamination remains a problem. Adding various inhibitors of fibroblast proliferation has met with lim- ited success. The identification of factors that permit the survival of islets in long-term culture and prevent fibroblast proliferation has been investigated by several groups in an effort to obtain pure monolayers of endocrine cells. These factors must permit endocrine cell survival, inhibit fibroblast proliferation, and allow normal growth and function of the islet. We (12) and others (13) (14) (15) (16) (17) examined the feasibility of using specific ligands to transport toxins into cells. The FGFsaporin mitotoxin fulfills most of the criteria required to grow pure islet-derived endocrine cells: it is specifically cytotoxic for contaminating fibroblasts and endothelial cells, has no cytotoxic effect on the p-cells of the islet, and does not impede the islet response to glucose in terms of insulin release. The data presented herein, however, do not address the issue of cytotoxicity to other non-p-cells in the islet or to islet p-cells that may undergo cell divisions in culture; such considerations may be important for the long-term function of islets. Thus, this study represents a potentially significant step in the development of the methods necessary to grow purified islets for physiological and clinical studies and, perhaps, transplantation.
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